Background Many women of reproductive age have depression, necessitating therapy with either a tricyclic antidepressant drug or a drug, such as fluoxetine, that inhibits the reuptake of serotonin. Whether these drugs affect fetal neurodevelopment is not known.
Postnatal Assessment
The first postnatal assessment occurred six to nine months after delivery. During this interview the mother was questioned about the course of her pregnancy after the initial meeting and was asked to verify the duration of treatment with tricyclic antidepressant drugs or fluoxetine during gestation, the dose of the drug, illnesses during pregnancy, and perinatal and postnatal complications. Details about the type of delivery, the perinatal period, and the times at which her child reached developmental milestones were also collected. This assessment also included a written report from the physician caring for the child.
Neurobehavioral Testing
All children were assessed by a psychometrician who did not know the nature of the intrauterine exposure. To assess neuro-cognitive development, children between 16 and 30 months of age were tested with the Bayley Scales of Infant Development [21] and older children were tested with the McCarthy Scales of Children's Abilities. [22] The temperament and behavior of children up to 24 months of age were evaluated with age-appropriate Carey Temperament Scales, [23, 24] The mother's level of depression and function from the birth of the infant to the time of the neurobehavioral assessment were evaluated with the Global Assessment Scale, which rates a subject's lowest level of functioning by selecting the lowest range that describes his or her functioning on a continuum of mental illness [29] ; the Center for Epidemiologic Studies Depressed Mood Scale, a 20-item scale that measures symptoms of depression for both epidemiologic research and clinical purposes [30] ; and the Index of Parental Attitudes, a 25-item scale designed to measure the extent, severity, or magnitude of problems in the parent-child relationship as seen and reported by a parent.
[31] As part of these assessments we recorded whether the mother continued drug therapy in the postpartum period, and if so, for how long.
Statistical Analysis
The outcome measures in each of the three groups were compared by one-way analysis of variance and Tukey's multiple-range test. All statistical tests were two-tailed.
Subsequently, multiple regression analysis was conducted to determine the effects of potential confounders on the outcome measures.
Differences in proportions among the groups were compared by the chi-square test. -------------*Plus-minus values are means +/-SD.
Testing occurred between 16 and 86 months of age (mean, 33 +/-14). †The P values correspond to the overall heterogeneity of the three groups. 
* Plus-minus values are mean +/-SD. † The children were tested between 16 and 86 months of age (mean, 33 +/-14).
The Bayley and McCarthy Scores are typical for this age. The normal range for both tests is 100 +/-1 SD. Lower scores mean lower cognitive function.
The mean Reynell score in normal children of this age is 0±1 (range of possible scores, -3 to +3).
Multiple regression ion analysis was used after adjustment for children's age; maternal IQ, socioeconomic status, score on the Epidemiologic Studies Depressed Mood Scale, and score on the Global Assessment Scale; and duration of exposure to drug (first trimester vs. entire pregnancy). CI denotes confidence interval.
